Baseline characteristics of matched TH and control patients
| Characteristic | TH group (n=47) | Control group (n=47) |
| NICU care, n (%) | 25 (53.2) | 25 (53.2) |
| Male gender*, n (%) | 24 (51.1) | 25 (53.2) |
| Sarnat stage II, n (%) | 39 (83.0) | 39 (83.0) |
| Sarnat stage III, n (%) | 8 (17.0) | 8 (17.0) |
| GA weeks (mean (SD)) | 38.89 (1.61) | 38.94 (1.55) |
| Cord pH (mean (SD)) | 6.96 (0.18) | 6.99 (0.19) |
| Cord base deficit, mmol/L(mean (SD)) | −14.87 (10.60) | −14.78 (6.57) |
| Apgar (mean (SD)) | 3.93 (2.15) | 4.78 (2.56) |
*One male in the TH group and two in the control group were not matched for gender.
GA, gestational age; NICU, neonatal intensive care unit; TH, therapeutic hypothermia.